Global Leading Market Research Publisher QYResearch announces the release of its latest report “Food Safety Immunoaffinity Columns (IAC) – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Food Safety Immunoaffinity Columns (IAC) market, including market size, share, demand, industry development status, and forecasts for the next few years.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5984875/food-safety-immunoaffinity-columns–iac
The global Food Safety Immunoaffinity Columns (IAC) market has emerged as a critical component in the contamination detection value chain, particularly for mycotoxin monitoring in food and feed. As of 2025, the market was valued at approximately US340million,accordingtoconsolidatedestimatesfromGlobalInfoResearchsupply−sidemodeling.Withanacceleratingcompoundannualgrowthrate(CAGR)of6.8340million,accordingtoconsolidatedestimatesfromGlobalInfoResearchsupply−sidemodeling.Withanacceleratingcompoundannualgrowthrate(CAGR)of6.8 560 million by the end of the forecast period. The primary growth drivers include stricter international food safety regulations, increasing mycotoxin outbreaks linked to climate volatility, and rising demand for rapid, high-specificity purification tools across grains, feed ingredients, and processed foods.
Mycotoxin immunoaffinity columns are specialized chromatographic tools designed for the selective extraction and purification of mycotoxins—toxic secondary metabolites produced by fungal species such as Aspergillus, Fusarium, and Penicillium. These toxins, including aflatoxins, ochratoxin, zearalenone, deoxynivalenol (DON), and fumonisins, pose significant chronic and acute risks to human and animal health. Unlike conventional solid-phase extraction (SPE) methods, IAC offers superior specificity, lower matrix interference, and higher recovery rates, making them the preferred choice in both routine quality control and official reference methods (e.g., AOAC, EU Regulation 401/2006).
2. Strategic Segmentation by Contaminant Type and Application
The Food Safety Immunoaffinity Columns (IAC) market is segmented as below – by contaminant type, end-use application, and region. From a industry stratification perspective, a critical distinction exists between discrete manufacturing (e.g., batch testing in grain processing facilities) and process manufacturing (continuous flow systems in large feed mills or dairy plants). IAC products for discrete manufacturing prioritize high batch-to-batch consistency and ease of handling, while process-oriented applications demand faster flow rates and compatibility with automated liquid handling platforms.
By Contaminant Type (Product Family)
- Aflatoxins – Dominant segment, accounting for ~38% of 2025 global revenue, driven by strict peanut, maize, and tree nut import standards (e.g., EU MRL 2–4 µg/kg).
- Ochratoxin – High penetration in wine, coffee, and cereal segments. Recent EU regulation (2025/1023) lowered MRL for infant cereals further.
- Zearalenone – Strong demand from animal feed sector, especially swine production. Nordics and North Central US reported elevated incidence in 2025 corn harvest.
- Deoxynivalenol (DON) – Fastest-growing segment, CAGR projected at 7.2% 2026–2032, due to increasing Fusarium head blight events in Europe and Canada.
- Fumonisins – Critical for maize-based foods. South Africa and Brazil implemented stricter monitoring post-2024 contamination alerts.
- Others (including T-2/HT-2, citrinin).
By Application
- Grains – Wheat, maize, barley, rice, oats. Largest share (>55% in 2025). China’s National Food Safety Standard (GB 2761-2025) added four new mycotoxin limits.
- Feed – Fastest-growing application (+7.8% CAGR). Aflatoxin B1 carry-over into milk remains a top enforcement priority.
- Others – Nuts, spices, dried fruits, baby foods, and herbal ingredients.
3. Competitive Landscape: Key Manufacturers and Technology Positioning
The market features a mix of established immunoaffinity specialists and emerging regional suppliers. Leading companies include:
Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM (now part of MilliporeSigma), Ring Biotechnology, R-Biopharm AG, CHROMATIFIC, Welch Materials, Neogen, Kwinbon Biotechnology, Shandong Meizheng Bio-Tech, Pribolab, Jiangsu Suwei Micro-Biology Research, Shandong Lvdu Bio-Sciences & Technology, Jiangsu Wisdom Engineering & Technology, BIOCOMMA, Beijing Nano-Ace Technology, Femdetection, Wuhan Huamei Wisherkon Biotech, Changsha Huaxue Biological Technology, Anavo, Shandong Vnya Bio-technology, Guanyibio, Prufunglab.
Exclusive observation (Global Info Research analysis): Chinese domestic manufacturers now represent ~32% of global IAC unit volume, up from 19% in 2022, driven by import substitution policies and cost-effective production of aflatoxin and ochratoxin columns. However, premium segments (DON, fumonisins, multi-mycotoxin columns) remain dominated by European and North American suppliers due to higher cross-reactivity control and regulatory certifications (e.g., AOAC RI, ISO 17025 validation).
4. Recent Technical and Policy Developments (Last 6 Months)
- September 2025: The European Commission updated Commission Regulation (EU) 2025/1881, harmonizing mycotoxin sampling and analysis methods, making IAC the recommended confirmatory technique for official control labs.
- November 2025: A large US feed mill recall (over 12,000 tons of maize gluten meal) due to fumonisin contamination above FDA guidance levels sparked a 15% surge in IAC procurement across Midwest livestock operations.
- January 2026: China’s General Administration of Customs (GAC) launched a six-month special inspection campaign targeting aflatoxin M1 in imported dairy powders; direct result: Q1 2026 IAC sales to Chinese dairy labs tripled versus Q1 2025.
Technical difficulty highlight: Multi-mycotoxin IAC columns enabling simultaneous extraction of 6+ analytes remain technically challenging due to antibody cross-reactivity and reduced binding capacity. Only three manufacturers currently supply validated multi-toxin columns meeting ISO 15189 lab accreditation requirements.
5. Regional Outlook and Strategic Recommendations
North America leads in revenue share (~34% in 2025), followed by Europe (30%) and Asia-Pacific (28%). The fastest growth is in Southeast Asia and India, where food processing FDI and domestic food safety laws (e.g., FSSAI’s 2025 Mycotoxin Control Guidelines) drive demand for affordable IAC kits.
For new entrants and suppliers, Global Info Research recommends:
- Differentiate through fast-elution IAC formats (<15 min total workflow) for high-throughput labs.
- Offer deoxynivalenol + zearalenone duplex columns, a growing request from process manufacturing facilities.
- Invest in digital quality traceability – QR-coded columns with lot-specific performance certificates are increasingly required by multinational food firms.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
Global Info Research
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
